We are live on ! Find out more
Bleichroeder

Bleichroeder Portfolio holdings

AUM $1.02B Turnover 33.63%
1-Year Est. Return 33%
This Fund
S&P 500
This Quarter Est. Return
-3.15%
1 Year Est. Return
+33%
3 Year Est. Return
+222.49%
5 Year Est. Return
+219.92%
10 Year Est. Return
–
AUM
$1.02B
AUM Growth
+$457M
Cap. Flow
+$530M
Cap. Flow %
52.15%
Top 10 Hldgs %
44.01%
Holding
113
New
35
Increased
8
Reduced
7
Closed
3
Avg Time Held
2 years
Top 10 Avg Time Held
2.1 years
Top 20 Avg Time Held
1.4 years

Top Buys

Rank Stock Value
1
PSQL icon
Pasqal Holding SA Ordinary Share
PSQL
+$31.7M
2
MDLN icon
Medline Inc
MDLN
+$18.4M
3
AVGO icon
Broadcom
AVGO
+$17.9M
4
A icon
Agilent Technologies
A
+$17.9M
5
TSM icon
TSMC
TSM
+$17.7M

Top Sells

Rank Stock Value
1
IRD icon
Opus Genetics
IRD
+$2.08M
2
LIN icon
Linde
LIN
+$1.77M
3
OWLT icon
Owlet
OWLT
+$987K
4
FEAM icon
5E Advanced Materials
FEAM
+$638K
5
PYPL icon
PayPal
PYPL
+$220K

Sector Composition

Rank Sector Weight
1 Miscellaneous 23.67%
2 Technology 20.28%
3 Industrials 15.62%
4 Financials 13.79%
5 Healthcare 12.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
NMTC icon
76
NeuroOne Medical Technologies
NMTC
$6.78M
$687K 0.07%
666,666
– –
2025 Q2
5 quarters
MODD icon
77
Modular Medical
MODD
$18.7M
$674K 0.07%
336,986
– –
2024 Q1
10 quarters
MAIA icon
78
MAIA Biotechnology
MAIA
$61.8M
$590K 0.06%
500,000
– –
2026 Q1
2 quarters
DETX icon
79
Liberty Defense Holdings
DETX
$6.82M
$583K 0.06%
277,777
– –
2026 Q2
1 quarter
CLRB icon
80
Cellectar Biosciences
CLRB
$11.4M
$531K 0.05%
288,679
– –
2025 Q3
4 quarters
PXLW icon
81
Pixelworks
PXLW
$33.1M
$524K 0.05%
73,769
-10,500
-12% -$68.5K
2025 Q4
3 quarters
LLYVA icon
82
Liberty Live Group Series A
LLYVA
$9.45B
$502K 0.05%
6,047
– –
2023 Q3
12 quarters
ICCC icon
83
ImmuCell
ICCC
$97.7M
$490K 0.05%
50,000
– –
2021 Q2
21 quarters
PHYS icon
84
Sprott Physical Gold
PHYS
$14.2B
$392K 0.04%
12,540
– –
2019 Q4
27 quarters
NSRX icon
85
Nasus Pharma
NSRX
$33.6M
$332K 0.03%
89,848
– –
2026 Q1
2 quarters
BNY icon
86
Bank of New York Mellon
BNY
$103B
$289K 0.03%
2,000
– –
2020 Q1
26 quarters
BEAT icon
87
Heartbeam
BEAT
$25M
$229K 0.02%
625,000
– –
2026 Q2
1 quarter
MRLN icon
88
Merlin Inc
MRLN
$116M
$188K 0.02%
+100,000
New +$343K
2026 Q3
0 quarters
LION icon
89
Lionsgate Studios
LION
$4.18B
$184K 0.02%
16,413
– –
2025 Q3
4 quarters
TMDX icon
90
Transmedics
TMDX
$3.17B
$175K 0.02%
2,100
– –
2025 Q4
3 quarters
XOM icon
91
ExxonMobil
XOM
$696B
$175K 0.02%
1,075
– –
2020 Q2
25 quarters
CDNS icon
92
Cadence Design Systems
CDNS
$88.6B
$173K 0.02%
525
– –
2020 Q2
25 quarters
CRIS icon
93
Curis
CRIS
$1.08M
$160K 0.02%
190,116
– –
2020 Q4
23 quarters
MSAI icon
94
MultiSensor AI
MSAI
$7.87M
$149K 0.01%
30,562
– –
2024 Q2
9 quarters
SIRI icon
95
SiriusXM
SIRI
$10.7B
$131K 0.01%
5,061
– –
2024 Q3
8 quarters
PYPL icon
96
PayPal
PYPL
$49.2B
$68.3K 0.01%
1,300
-4,000
-75% -$220K
2020 Q1
26 quarters
ERNAW icon
97
Ernexa Therapeutics Warrants
ERNAW
$351K
$63.4K 0.01%
2,000,000
– –
2026 Q1
2 quarters
ARKF icon
98
ARK Blockchain & Fintech Innovation ETF
ARKF
$697M
$54.6K 0.01%
1,200
– –
2022 Q1
18 quarters
ARKW icon
99
ARK Next Generation Technology ETF
ARKW
$1.63B
$48K ﹤0.01%
300
– –
2022 Q1
18 quarters
ARKG icon
100
ARK Genomic Revolution ETF
ARKG
$1.89B
$44.7K ﹤0.01%
825
– –
2022 Q1
18 quarters

Similar funds

Bleichroeder's Q3 2026 Portfolio in Review

As of Q3 2026, Bleichroeder held 113 positions worth $1.02B, up 82% from $559M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Bleichroeder deployed $530M of net new capital in Q3 2026, opening 35 new positions and adding to 8 existing holdings. Its largest new stake was Pasqal Holding SA Ordinary Share: 3,496,313 shares worth $22.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Opus Genetics, an estimated $2.08M trimmed.

  • Bleichroeder's largest Q3 2026 buy was Pasqal Holding SA Ordinary Share: 3,496,313 shares worth $22.2M.
  • Bleichroeder added most to S&P Global in Q3 2026, an estimated $16M increase.
  • Bleichroeder's biggest Q3 2026 reduction was Opus Genetics, cutting an estimated $2.08M.
  • Bleichroeder fully exited Owlet in Q3 2026, selling an estimated $987K.
  • Bleichroeder's ten largest holdings make up 44% of its $1.02B portfolio in Q3 2026.
  • Bleichroeder opened 35 new positions and closed 3 in Q3 2026.
  • Bleichroeder's portfolio value rose 82% quarter-over-quarter to $1.02B.

Based on Bleichroeder's 13F filing for Q3 2026, filed 13 Nov 2026.